Sökning: "GnRH agonist"
Visar resultat 1 - 5 av 7 avhandlingar innehållade orden GnRH agonist.
Sammanfattning : Introduction: Premenstrual Dysphoric Disorder (PMDD) is a condition that affects about 2-6% of women of reproductive age. The relation to ovarian steroids is apparent as symptoms are absent during anovulatory cycles. LÄS MER
2. Is it Just the Hormones? : Sex Steroids, Chronic Stress and Violence in Premenstrual Dysphoric Disorder
Sammanfattning : Premenstrual depressive symptoms and mood swings affect 3-8% of women in fertile age. The female hormones are believed to be the cause. Progesterone is well studied, but estrogen is not, and either are other causes such as intimate partner violence and chronic stress. LÄS MER
3. Neoadjuvant hormone treatment in localized prostate cancer : A clinical and histopathological study
Sammanfattning : Neoadjuvant hormone treatment in localized prostate cancer, a clinical andhistopathological studyMagnus Hellström, Karolinska Institute Danderyd Hospital, Division of Urology, S-182 88 Danderyd, SwedenSurgical treatment of localized prostate cancer may be hampered by the spread of cancer through theprostate capsule and in the surgical margins. The prostate is dependent on androgen hormones for itsgrowth and function. LÄS MER
4. Acute intermittent porphyria, women and sex hormones. Screening for hepatocellular carcinoma in porphyria
Sammanfattning : Background: Porphyrias are inherited disorders with impaired heme biosynthesis. Acute intermittent porphyria (AIP) is the most common porphyria in Sweden. AIP attacks may be life-threatening. Female sex hormones are regarded as important precipitating factors. LÄS MER
Sammanfattning : Every cancer tumor is unique, with characteristics that change over time. The evolution of a full-blown malignancy from a single cell that gives rise to a heterogeneous population of cancer cells is a complex process. LÄS MER